Breaking News

Australia Is Expected To Receive AstraZeneca's Covid-19 Vaccine Within A Few Months


Australia Is Expected To Receive AstraZeneca's Covid-19 Vaccine Within A Few Months

Prime Minister Scott Morrison said Australia is expected to receive its first potential batch of Covid-19 vaccine in January, as the number of new daily infections in the country's viral hotspot drops to a lowest in 10 weeks.

Mr. Morrison said his government signed an agreement with CSL to produce two vaccines - one developed by rival AstraZeneca and University of Oxford, and another developed in CSL's own lab, with the University of Queensland.

Mr. Morrison added that Australia will receive 3.8 million doses of the AstraZeneca vaccine in January and February next year, which are currently undergoing final stage clinical trials in the UK, Brazil and South Africa.

AstraZeneca's candidate, AZD1222, is seen as the leading model in the global vaccine supply race. In August, Australia announced that it plans to buy AZD1222, along with an agreement of intent from CSL to manufacture it. That plan was put into doubt as CSL announced shortly that it would prioritize production of its own vaccine.

Validation Australia will also buy CSL if successful trials appear to be the culmination of an agreement to buy both vaccines. The CSL vaccine will begin phase two clinical trials in late 2020, meaning the vaccine could hit the market as early as mid-2021.

"By securing production and supply agreements, Australians will be among the first in the world to receive a safe and effective vaccine, if it passes phase testing."

said Mr. Morrison.

Mr. Morrison further revealed that if both vaccines pass the clinical trials, Australia will spend $ 1.24 billion on a total of nearly 85 million doses. The deal came when the Australian state of Victoria said 41 cases of Covid-19 infection were detected in the past 24 hours, the lowest increase in a day since June 26.

Australia's second most populous state was the focus of the second wave, and now accounts for about 75% of the 26,320 cases and 90% of the 762 deaths in the country. The southeastern state of the country on September 6 extended a stringent blockade in the capital Melbourne until September 28 as the daily infection rate fell more slowly than expected.


No comments